跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 107 条关于
“ornithine carbamoyltransferase”
全部
107
临床试验
59
药物
16
机构
0
资讯
32
去年
Ravicti Receives Regulatory Approval in Saudi Arabia, Qatar, and Kuwait for Urea Cycle Disorders
去年
Yaqrit Advances L-ornithine Phenylacetate to Phase 3 for Acute Hepatic Encephalopathy Treatment
去年
Arcturus Therapeutics Initiates Phase 2 Trials for mRNA Therapies Targeting Cystic Fibrosis and OTC Deficiency
2年前
Ultragenyx Announces Preliminary 2023 Revenue and 2024 Financial Guidance
去年
Arcturus Therapeutics to Present Phase 2 Data for ARCT-810 mRNA Therapy in Rare Genetic Disorder
去年
Arcturus Therapeutics Poised for Growth with Cystic Fibrosis and OTCD Therapies
去年
Arcturus Therapeutics Advances mRNA Pipeline and Reports Q3 2024 Financial Results
去年
Precision BioSciences' ARCUS Platform Shows Promising Clinical Outcomes in Gene Editing Trial
去年
Eflornithine Combo Fails to Meet Primary Endpoint in Phase III Brain Cancer Trial
去年
Arcturus Therapeutics' COVID-19 Vaccine Kostaive Receives Positive EMA Recommendation
第 1 页，共 4 页
上一页
下一页
